Industry news

Share this article:
GlaxoSmithKline is partnering with the Healthcare Communication & Marketing Association (HCMA) to provide education, training and support to members on its Value of Medicine Program, aimed at getting the industry's side out on issues including drug costs, marketing and promotion, drug importation, drug safety and the Medicare prescription drug benefit. “HCMA members hold key marketing and education positions in the industry,” said Jay Bolling, president of HCMA and president of Roska Healthcare Advertising. “This strategic partnership with GSK will provide our members with the tools and information necessary to repair the perception the healthcare profession and patients have of our industry.”
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Novartis apologizes for slow reporting

Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

Pfizer buys two Baxter vaccines

The meningitis and encephalitis medications earned a combined $300 million last year.